Authors: van den Brink, EN Turenhout, EAM Bank, CMC Fijnvandraat, K Peters, M Voorberg, J

Citation: En. Van Den Brink et al., Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain, BLOOD, 96(2), 2000, pp. 540-545

Authors: van den Brink, EN Turenhout, EAM Davies, J Bovenschen, N Fijnvandraat, K Ouwehand, WH Peters, M Voorberg, J

Citation: En. Van Den Brink et al., Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes, BLOOD, 95(2), 2000, pp. 558-563

Authors: van den Brink, EN Timmermans, SMH Turenhout, EAM Bank, CMC Fijnvandraat, K Voorberg, J Peters, M

Citation: En. Van Den Brink et al., Longitudinal analysis of factor VIII inhibitors in a previously untreated mild haemophilia A patient with an Arg(593)-> Cys substitution, THROMB HAEM, 81(5), 1999, pp. 723-726

Authors: van Ommen, CH Fijnvandraat, K Vulsma, T Delemarre-van de Waal, HA Peters, M

Citation: Ch. Van Ommen et al., Acquired protein S deficiency caused by estrogen treatment of tall stature, J PEDIAT, 135(4), 1999, pp. 477-481

Authors: van Mourik, JA Boertjes, R Huisveld, IA Fijnvandraat, K Pajkrt, D van Genderen, PJJ Fijnheer, R

Citation: Ja. Van Mourik et al., von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation, BLOOD, 94(1), 1999, pp. 179-185